Matthieu Texier

3.6k citations
31 papers · 1.7k indexed · 2 hit papers · h-index 12
Topics
Cancer Immunotherapy and Biomarkers (11 papers)Lung Cancer Treatments and Mutations (9 papers)Colorectal Cancer Treatments and Studies (4 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe Lancet Oncology
Partner nations
FranceSpainItaly

In The Last Decade

Matthieu Texier

31 papers receiving 1.6k citations

Hit Papers

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies a...201520262018202220162015250500750

Peers

Matthieu Texier
Comparison fields: 5 of 77
  • Oncology 1.3k
  • Immunology 567
  • Pulmonary and Respiratory Medicine 321
  • Molecular Biology 266
  • Surgery 178
Replace C. Boutros with:
C. Boutros France
Diégo Tosi France
Hideya Takeuchi Japan
Akin Atmaca Germany
Parisa Momtaz United States
Anne Cairoli Switzerland
Sheena Bhalla United States
Tong-Yu Lin China
Sofiya Latifyan Switzerland
Keyvan Shabafrouz Switzerland
Matthieu Texier relative to C. Boutros France C. Boutros's profile →
Citations per field
00.5×1.5×2.1×
C. Boutros · 1×
Citations per year

Countries citing papers authored by Matthieu Texier

Since Specialization
Citations

This map shows the geographic impact of Matthieu Texier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Texier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Texier more than expected).

Fields of papers citing papers by Matthieu Texier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthieu Texier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Texier. The network helps show where Matthieu Texier may publish in the future.

Co-authorship network of co-authors of Matthieu Texier

This figure shows the co-authorship network connecting the top 25 collaborators of Matthieu Texier. A scholar is included among the top collaborators of Matthieu Texier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthieu Texier. Matthieu Texier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 4
3 35
4 1
5 18
6 16
7 12
8 5
9 15
10 2
11 7
12 2
13 49
14 3
15 9
16 1
17 19
18 1
19
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combinationbreakdown →
813
20 20

About Matthieu Texier

Matthieu Texier is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (9 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (567 citations) and Pulmonary and Respiratory Medicine (321 citations). Matthieu Texier has collaborated with scholars based in France, Spain and Italy. Frequent co-authors include Stéphane Champiat, Caroline Robert, Émilie Lanoy, Jean‐Charles Soria, Christine Mateus, Émilie Routier, C. Boutros, Aurélien Marabelle, Olivier Lambotte and Alexander M.M. Eggermont. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026